bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

Robust clustering and interpretation of
scRNA-seq data using reference component
analysis
Florian Schmidt1* , Bobby Ranjan1* , Quy Xiao Xuan Lin1 , Vaidehi Krishnan2 , Ignasius Joanito1 , Mohammad Amin
Honardoost13 , Zahid Nawaz1 , Prasanna Nori Venkatesh1 , Joanna Tan1 , Nirmala Arul Rayan1 , S.Tiong Ong24 , and Shyam
Prabhakar1,
1

Laboratory of Systems Biology and Data Analytics, Genome Institute of Singapore, A*STAR, 60 Biopolis St, 138672, Singapore, Singapore
2
DUKE-NUS Medical School, 8 College Rd, 169857 Singapore, Singapore
3
Department of Medicine, School of Medicine, National University of Singapore, 1 Kent Ridge Road, level 10, NUHS Tower Block, 119228 Singapore, Singapore
4
Department of Medicine, Duke University Medical Center, Durham, 27710, NC, USA
*
contributed equally

FT

cell cluster in transcriptome space represents a distinct cell
type or state. There are two established paradigms to address the SC clustering problem: [i] unsupervised (de novo)
clustering (4) and [ii] supervised approaches that use reference data sets to either cluster cells or to classify cells into
cell types (5, 6). The graph-based clustering methods S EU RAT (7) and S CANPY (8) are among the most prevalent de
novo clustering approaches.
However, SC clustering is a challenging algorithmic problem: 1) cells may cluster by technical variation and batch
effects rather than biological properties (4), 2) scRNA-seq
data tend to be noisy, primarily due to sampling noise and
3) the gene expression matrix can be very large, since modern datasets commonly include > 100, 000 cells. Consequently, different algorithms can return highly divergent clusterings, i.e. partitions of cells into clusters, of the same input
dataset (9). Moreover, de novo clustering requires an errorprone, time-consuming manual step of assigning cell clusters
to cell types (annotation) based on subjective evaluation of
the expression of literature marker genes. Supervised clustering and supervised cell type annotation algorithms have
been developed to address these limitations (6).
Previously, we proposed Reference Component Analysis
(RCA) for supervised clustering of scRNA-seq data guided
by a panel of reference transcriptomes (5). Unlike methods
such as S INGLE R (10) or SC M ATCH (11), the aim of RCA is
not cell type annotation. Rather, RCA was designed to cluster cells in the space of reference transcriptome projections.
As we show below, this reference-based clustering approach
is applicable even in situations where the dataset contains cell
states not present in the reference panel. To the best of our
knowledge, RCA is the only supervised clustering algorithm
for scRNA-seq data. However, the original version of RCA
cannot scale to datasets larger than 20, 000cells on a highend laptop, used only a single reference panel, did not implement differential expression and Gene Ontology (GO) enrichment analysis, was benchmarked on only a single Smart-seq
dataset and could not be easily integrated into existing data
analysis workflows.
To fully leverage the merits of supervised clustering, we

D

RA

Motivation: The transcriptomic diversity of the hundreds of cell
types in the human body can be analysed in unprecedented detail using single cell (SC) technologies. Though clustering of cellular transcriptomes is the default technique for defining cell
types and subtypes, single cell clustering can be strongly influenced by technical variation. In fact, the prevalent unsupervised
clustering algorithms can cluster cells by technical, rather than
biological, variation.
Results: Compared to de novo (unsupervised) clustering methods, we demonstrate using multiple benchmarks that supervised
clustering, which uses reference transcriptomes as a guide, is robust to batch effects. To leverage the advantages of supervised
clustering, we present RCA2, a new, scalable, and broadly applicable version of our RCA algorithm. RCA2 provides a userfriendly framework for supervised clustering and downstream
analysis of large scRNA-seq data sets. RCA2 can be seamlessly incorporated into existing algorithmic pipelines. It incorporates various new reference panels for human and mouse,
supports generation of custom panels and uses efficient graphbased clustering and sparse data structures to ensure scalability. We demonstrate the applicability of RCA2 on SC data
from human bone marrow, healthy PBMCs and PBMCs from
COVID-19 patients. Importantly, RCA2 facilitates cell-typespecific QC, which we show is essential for accurate clustering
of SC data from heterogeneous tissues. In the era of cohortscale SC analysis, supervised clustering methods such as RCA2
will facilitate unified analysis of diverse SC datasets.
Availability: RCA2 is implemented in R and is available at
github.com/prabhakarlab/RCAv2
scRNA-seq | Clustering | Batch effects | Covid-19
Correspondence: prabhakar@gis.a-star.edu.sg

Introduction
Since its first usage in 2009 (1), single cell (SC) RNA sequencing (scRNA-seq) has quickly become the method of
choice for profiling gene expression in complex samples (2).
Due to the unprecedented resolution of scRNA-seq data, celltype-specific analysis of gene expression can now be performed easily and at low cost. SCTs are well-suited to characterize heterogeneous biological specimens, e.g. tumors (3).
Clustering is an essential step in SC data analysis, since each

Schmidt et al.

|

bioRÏ‡iv

|

February 17, 2021

|

1â€“10

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

MATERIALS AND METHODS
Projection to a reference. Given a reference data set R

containing n cell types and G marker genes as well as a
query data set Q containing i scs and C genes, we determine
a marker gene set M by intersecting G and C:
M = G âˆ© C.

(1)

The reference matrix R0 and set Q0 are generated by extracting the gene set M from R and Q, respectively. Next, RCA2
computes the correlation (default: Pearson(r)) between R0
and Q0 yielding a reference projection P for i scs to n cell
types:
P = r(R0 , Q0 ).
(2)
The projection matrix P is modified according to
P = |P|4 Â· sign(P).

(3)

Reference panels. RCA2 includes ten human reference

panels as well as two mouse reference panels (Sup. Section
1). Multiple panels can be used for reference projections simultaneously. Furthermore, RCA2 provides users with the
option to generate their own reference panel: the buildReferencePanel function considers a bulk gene expression matrix
(genes as rows and replicates as columns) of raw counts and
returns a reference panel that can be used with RCA2. Details
are provided in Sup. Section 2.1.
Annotation of cell types. RCA2 implements cell type as-

signment at the SC level following a strategy inspired by S IN GLE R (Sup. Section 2.2). To annotate cell types on the cluster level, we consider the cell type composition for each cluster based on the SC cell type assignment described above. If
the cell type distribution within a cluster is heterogeneous and
the proportion of the major cell type is below a user defined
threshold (default 50%), the cluster is labelled as Unknown.
Cluster specific quality control. Quality of scRNA-seq

data is usually assessed using NODG, nUMI and pMito metrics. RCA2 provides cluster-specific QC, allowing to impose
upper/lower bounds on QC metrics for each cluster independently.

RA

P is scaled to zero mean and unit variance. All matrices
are represented as sparse matrix R objects. The projection
is computed using the fastcor package (12). P can be visualized as a 2D and 3D UMAP.

PC space computed on the reference projection (not available
with hierarchical clustering). The clustering result is visualized in a heatmap, including quality control (QC) metrics:
number of detected genes (NODG), the percentage of mitochondrial genes (pMito) and the number of unique molecular
identifiers (NUMI). Reference cell types with a low variance
across all query cells are not shown.

FT

present RCA2, a new implementation of reference-based
clustering that addresses the above limitations. We show the
unique advantages of RCA2 by analyzing diverse scRNAseq data sets and show that supervised clustering can detect
novel disease/condition-specific cell states. Importantly, we
demonstrate that supervised clustering using RCA2 is exceptionally robust against batch effects on large scRNA-seq data
sets, rendering it the method of choice for the joint analysis
of heterogeneous cohort-scale datasets.

Clustering and interpreting the projection. RCA2 offers

D

three clustering algorithms: i) hierarchical clustering using
the memory efficient fastcluster (13) package, ii) sharednearest neighbour (SNN) clustering using dbscan (14) and
iii) graph based clustering using the Louvain algorithm (7).
The depth to cut the dendrogram in hierarchical clustering
is a parameter (default 1). The SNN algorithm used in dbscan has three parameters: k (neighborhood size of the SNN
graph), eps (two cells are only reachable from each other if
they share at least eps nearest cells) and min âˆ’ pts (minimum number of nearest neighbours for a cell to be considered a core cell). To guide the users choice on parameters
for graph based clustering, a 3D figure illustrating how the
final number of clusters depends to the used parameters can
be generated. The Louvain algorithm requires only the resolution parameter. A line-plot illustrating how the resolution
influences the number of identified clusters can be generated.
As input, all clustering methods use either a distance matrix
D computed from P according to
D = 1 âˆ’ r(P),

(4)

where r(P) is the cell-to-cell similarity using correlation
(Pearson(default in this manuscript), Spearman or Kendal)
as a metric in the cell type space or an embedding of cells in
2

|

bioRÏ‡iv

Differentially expressed gene computation and enrichment analysis. Differentially expressed genes (DEGs) are

calculated between clusters, either in a 1 vs. all (default) or a
pairwise fashion using a modified version of S EURATâ€™s DEG
calling function. We incorporated a mean expression threshold, which is either a user defined value or automatically determined as a trimmed mean excluding the top n (default: 5)
genes with the highest expression. Geneâ€™s with a cluster specific expression below the threshold are not considered for
the DE test. DEGs computed in this way are used to perform
enrichment analysis of GeneOntology (GO) terms or KEGG
Pathways, for which RCA2 incorporates the C LUSTER P RO FILER R-package (15). Details are provided in Sup. Section
2.3.
Considered scRNA-seq data sets and data processing.
10X PBMC data sets. We downloaded scRNA-seq data of

5025 PBMCs generated using Chromium SC 30 Reagent
Kits v3 from 10X (single-cell-gene-expression/datasets/
3.0.2/5k_pbmc_protein_v3). In total, 4249 cells passed QC
(Sup. Table 1). The data set was projected against the
Novosthern reference panel comprised of 15 hematopoietic cell types (16) (Sup. Sec. 1).The resolution paSchmidt et al.

|

RCA2

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

COVID-19 PBMCs. A Seurat object with scRNA-seq data

studied by (22) was obtained from the COVID-19 Cell Atlas (covid19cellatlas.org). All 44, 721 cells were projected
against the global, Monaco, Novershtern, and CITE-seq
panel and clustered using the Louvain algorithm (resolution
1.3). Clusters were annotated according to reference projection profiles and marker gene expression. Marker genes for
each subset of developing neutrophils are computed using the
following DEG parameters: min.pct= 0.25, logfc.threshold=
1, and p_val_adjâ‰¤ 0.05. Sub-clustering and cell embedding of CD14 monocytes, intermediate monocytes, CD16
monocytes, myeloid dendritic cells (mDC), myelocytes, neutrophils and plasmablasts was conducted using S EURAT. The
union set of pair-wise DEGs between these cell types was
used as feature genes for PCA. DEGs were determined using the parameters: min.pct= 0.25, logfc.threshold= 1.5, and
p_val_adjâ‰¤ 0.05. For downstream clustering we used 18 PCs
and annotated clusters using marker genes.

D

RA

CITE-seq PBMC data sets. A Drop-Seq data set with
29, 929 genes profiled in 7, 985 cells and 10 antibodies was obtained from (17).
A 10x CITE-seq data
set with 7, 865 cells profiled on 33, 538 genes and
17 antibodies was obtained from 10x (single-cellgene-expression/datasets/3.0.0/pbmc_10k_protein_v3).
Both data sets were processed using S EURAT.
To
obtain a ground truth, we clustered cells in antibodyderived tags (ADT) space.
ADT data was normalized using the centered log ratio transformation (satijalab.org/seurat/v3.2/multimodal_vignette.html). All PCs
were selected for clustering using Louvain clustering. Since
the Drop-Seq data did not include a control for antibody
detection, clusters exhibiting noisy antibody detection or
those clusters not representing known immune cell type
signature (16, 18) were removed. In the 10x data, clusters
showing IgG1, IgG2a or IgG2b and clusters showing
promiscuous antibody expression were discarded. After QC
(Sup. Table 1), the Drop-Seq and 10x datasets contained
5, 925 and 6, 744 cells, respectively. The Drop-Seq and 10x
data sets were next merged with respect to their common
genes (13, 267). Using S EURATâ€™s FindMarker function, we
computed batch specific marker genes for each ADT cluster
in the merged data set using the parameters: min.pct= 0.5,
logfc.threshold= 1.5 and p_val_adjâ‰¤ 0.05. GO terms for
batch specific clusters are computed using C LUSTER P RO FILER utilising the org.Hs.eg.db database, and a q-value
threshold of 0.05.

quirement of at least 1, 000 nUMI, and a pMito rate between
2.5% and 10%, we projected the data against RCAâ€™s global
panel obtaining a classification into major groups (resolution
0.1) to perform cluster specific QC (Sup. Table 2). Final
cell types were identified upon QC using a resolution of 0.5.
Doublets were removed using D OUBLET F INDER (21). D OU BLET F INDER was run separately on the CD34+ and CD34populations using 20 PCs and a pNN value of 0.25 as well
as pk values of 0.005 and 0.01, respectively. The obtained
pANN values were merged to rank cells based on their doublet neighbourhood. A pANN threshold was derived considering both the expected number of doublets (â‰ˆ 1, 560) and by
examining the proportion of possible doublets in each cluster.

FT

rameter used for Louvain clustering was determined using a grid-search with a step-size of 0.05. DEGs between clusters are computed in a pairwise-manner using the parameters:min.pct= 0.5, logfc.threshold= 0.5 and
p_val_adjâ‰¤ 0.05. GO terms were computed using C LUS TER P ROFILER utilising the org.Hs.eg.db database, and a qvalue threshold of 0.05.

Rheumatoid arthritis scRNA-seq data set. The scRNA-seq

data set of 10, 001 cells from Rheumatoid Arthritis (RA) samples, obtained from (19), was processed using S EURAT. Cells
were filtered based on the QC criteria provided in Sup. Table
1. This data was generated using CEL-Seq2 (20) after sorting for B cells (CD45+CD3-CD19+), T cells (CD45+CD3+),
monocytes (CD45+CD14+), and stromal fibroblasts (CD45CD31-PDPN+) from synovial tissues of ultrasound-guided
biopsies or joint replacements of RA patients. Cell type annotation based on the authors cell sorting strategy is used as
a ground truth.
Bone-marrow scRNA-seq data set. We obtained eight human

bone marrow (BM) specimens from STEMCELL technologies and generated ten scRNA-seq data sets using the 10X
5â€™scRNA-seq protocol (see Sup. Section 2.4) by separating
the cells into CD34+ and CD34- cell fractions followed by
sequencing on a HiSeq4000. Preprocessing was done using the 10X CellRanger pipeline (3.0.1) using the hg38 reference genome resulting in a data set comprised of 45, 363
cells, capturing 24, 206 genes. Considering only an initial reSchmidt et al.

|

RCA2

AML dataset. The AML data scRNA-seq data set 809653 was

obtained from the zenodo archive of (23) at 10.5281/zenodo.3345981. No additional QC was performed. The data
was projected using RCA2s Multi Panel Projection function
with default parameters. The data was clustered using hierarchical clustering at deep split 1.
Methods used for batch effect benchmarking. To

benchmark the batch effect robustness of RCA2, we considered Seurat, Scran (24), Scanpy, S EURAT with CCA,
MNNCorrect (25) and Scanorama (26). Seurat (with and
without CCA) (3.2) was used as recommended in its documentation (satijalab.org/seurat/vignettes.html). For Scran
(1.18.1), we followed the tutorial from bioconductor (bioconductor.org/packages/
release/bioc/html/scran.html).
Highly variable genes are used as features (FDR
â‰¤ 0.05) and the walktrap community detection algorithm was used for clustering.
We used MNNCorrect (batchelor R package (1.6)) according to bioconductor.org/packages/release/bioc/html/batchelor.html.
Furthermore,
we
used
Scanpy
(1.5.1)
(scanpy.readthedocs.io/en/stable/) and Scanorama (1.6)
(nbisweden.github.io/workshop-scRNAseq). We also exploit
SCTransform (27) to normalize data before analyzing it with
Seurat or Seurat with CCA.
bioRÏ‡iv

|

3

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

Silhouette Index for quantifying batch effect. The Sil-

offers a significant speed up of several folds in computing the
projection (Fig. 2a, Sup. Sec. 2.5).
Rising cell numbers cause memory consumption to rise,
hence RCA2 uses a memory-efficient implementation of hierarchical clustering (31) and provides two graph-based clustering methods as an alternative: SNN clustering (DBSCAN)
o(x) âˆ’ w(x)
and Louvain clustering as used in S EURAT. The latter two
S(x) =
,
(5)
max(o(x), w(x))
are not only faster than hierarchical clustering, but also require less memory (O(nk) vs O(n2 ), where n is the numwhere o(x) is the smallest mean between-cluster distance and
ber of cells and k is the number of nearest neighbours; Fig.
w(x) is the mean within-cluster distance for cell x defined as
2b (Sup. Sec. 2.5). To aid in parameter selection RCA2
provides visualizations on how parameter settings influence
X
X
1
1
o(x) = min
d(x, y), w(x) =
d(x, y), cluster numbers (Sup. Fig. 3, 4). These modifications render
cz 6=cx |cz |
|cx | âˆ’ 1
yâˆˆcz
yâˆˆcx ,x6=y
RCA2 to be applicable even to datasets comprising millions
(6)
of cells. Note that unlike other SC clustering frameworks,
where we use Euclidean distance to compute the distance
RCA utilizes the reference projection to cluster cells in a cell
d(x, y) between cell x and cell y, cx âˆˆ C is the cluster astype space instead of a high-dimensional gene-space. Clussigned to cell x and |cx | is the size of that cluster. We obtain
tering results can be visualised as a heatmap and as 2D as
the average SI for each cluster by averaging the SI values over
well as 3D UMAPs (Sup. Fig. 5, 6). Compared to the preall cells in that cluster. Thereby, each cell type is given equal
vious visualization, RCA2 shows additional QC information
weight in the final SI score.
(NODG, nUMI, pMito) and removes cell types not showing
For S EURAT, S EURAT I NTEGRATION (CCA), SCRAN, MNsignificant variation in the correlation score to facilitate data
NC ORRECT and S CANPY, cell-cell distances are calculated
interpretation and outlier detection.
in principal component (PC) space considering the top 20
To complement the functionality of RCA2, we incorporated
PCs. For S CANORAMA, the dimensionality was fixed to 100,
SINGLE R/ SC M ATCH like assignment of cell types to individas recommended by the authors. For RCA, cell-cell distances
ual cells (10, 11). Exploiting RCA2â€™ S clustering algorithms,
were calculated in the reference projection space.
we also allow annotation on the cluster level (see Methods).
For further biological interpretation RCA2 identifies DEG in
Implementation and Availability. RCA2 is freely available
either a 1 vs all or a pairwise scheme. DEGs are visualized
at www.github.com/prabhakarlab/RCAv2. It is extensively
in heatmaps following the established S EURAT color scheme
tested with R versions â‰¥ 3.6 on Windows, Linux and Mac
(Sup. Fig. 7) and can be used as input for a GO-Term (32)
devices. Scripts to create the main figures and RDS files with
enrichment and KEGG pathway (33) analysis, providing bioR objects for the batch effect benchmarking, the 10X PBMC
logical insights on clusters beyond lists of marker genes (Sup.
data, the BM use case and the COVID-19 data are available
Fig. 8).
at Zenodo (10.5281/zenodo.4021967). Fastq files for the BM
data are available upon request.
Supervised clustering is robust to batch effects. On of
the major advantages of supervised clustering is its ability to
Results
reduce the contribution of unwanted variation, which manifests in the form of noise or technical variation. This is cruRCA2 is a comprehensive software solution for supercial in the prevention of batch effects. By projecting sc data
vised clustering and analysis of scRNA-seq data. The
onto a reference panel of purified transcriptomes, supervised
RCA2 workflow is shown in Fig.1. As input, RCA2 takes eiclustering is able to preserve only the cell type-specific variather raw or pre-processed scRNA-seq data and facilitates QC
tion and ignore variation from other sources. This is based on
either as a single operation on all cells or in a cluster-specific
the concept shown in Sup. Fig. 9, i.e. the batch effect expresmanner (Sup. Fig. 1, 2).
sion signature will be orthogonal to the signature of cell type
While the first release of RCA provided one reference
marker genes, because any two randomly selected vectors are
panel only, RCA2 includes twelve panels, for instance a
orthogonal in a high dimensional space.
microarray-based human cord blood cell panel with 15 imWe benchmarked RCA2s robustness to batch effects by
mune cell types (16), one related RNA-seq panel with 28 hucomparing its performance against several other commonly
man immune cell types (18), a panel based on CITE-seq data
used scRNA-seq clustering algorithms: S EURAT, S EURAT
containing 34 primary human cell types (29), one human priWITH SCT RANSFORM , M ULTI CCA, M ULTI CCA WITH
mary cell type panel based on ENCODE (30) RNA-seq data
SCT RANSFORM, S CRAN, S CANPY, MNN C ORRECT and
containing 97 cell types and a mouse ENCODE panel with
S CANORAMA.
15 cell types. A list of all panels is provided in Sup. Section
1. Also, RCA2 offers means for de-novo panel generation
The benchmarking relies on SI values to determine clustering
from user-provided transcriptomes (Sup. Sec. 2.4). Unlike
quality with respect to batches and cell types (28). A robust
the original RCA software, RCA2 allows SC data to be promethod has a low SI in separating batches and a high SI in
jected against several reference panels at the same time and
separating cell types.

D

RA

FT

houette Index (SI) of a cell measures how similar a cell is
to other cells within its own cluster, relative to cells in other
clusters (28). We compute SI S(x) for each cell x in the DE
gene-space defined by CITE-Seq antibody tags:

4

|

bioRÏ‡iv

Schmidt et al.

|

RCA2

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

AAAAAAA
AAAAAAA
AAAAAAA

External tool and pipelines
Cells

OR

2.2
â‹®
0.2

De-novo reference
panels
Cell types

â‹¯ 4.2
â‹±
â‹®
â‹¯ 9.2

Marker genes

Input to RCA

AAAAAAA
AAAAAAA
AAAAAAA

Pre-processed count matrix

Projection of scRNA-seq data to a reference panel
Cluster specific QC

ðœð¨ð«(ð‘ðžðŸðžð«ðžð§ðœðž, ðð®ðžð«ð²)

2.2
â‹®
0.2

ð‚ðžð¥ð¥ ð­ð¨ ðœðžð¥ð¥ ð­ð²ð©ðž ðœð¨ð«ð«ðžð¥ðšð­ð¢ð¨ð§

Single cells

â‹¯ 1.9
â‹±
â‹®
â‹¯ 9.2

Genes

pMito

Genes

Cell type

6.1
â‹®
2

Cell type

Before cluster specific QC

â‹¯ 0.0
â‹±
â‹®
â‹¯ 1

Single cells
â‹¯ 0.2
â‹±
â‹®
â‹¯ âˆ’0.8

AAAAAAA

Microarray
AAAAAAA

AAAAAAA
AAAAAAA
AAAAAAA

scRNA-seq

Cell type 3

Gene 3

Marker genes

AAAAAAA

Bulk RNA-seq

AAAAAAA

Cell types

NODG
After cluster specific QC

AAAAAAA
AAAAAAA

AAAAAAA

0.9
â‹®
0.01

Cell types

pMito

Pre-computed
reference panels

Reference
transcriptomes

Marker genes

AAAAAAA
AAAAAAA
AAAAAAA

Genes

Normalization and Quality Control

scRNA-seq data

Cell type 1

Gene 1

Clustering

Interpretation of clusters and reference projection

NODG

DE heatmaps with QC data

Hierarchical

Graph-based

Projection Heatmaps

Projection UMAPs (2D/3D)

Computation of DE genes
Cluster1

UMI counts scaled (right) or unscaled (left)

Cluster2
1.CTCF
2.EGR1

Cluster1

------------

Cluster2

------------

------------

Cluster3

-----------

------------

Enrichment analysis (GO/KEGG)

Cluster3
1.TP53
2.ERBB2
1.AHR
2.GLIS1
------------

Dotplots

Barplots

GOplots

FT

Pairwise comparison of clusters

Fig. 1. RCA2 takes two types of scRNA-seq data as input: 1) CellRanger output files and 2) data preprocessed elsewhere, which can be loaded as a gene x cell count matrix.
Reference datasets in RCA2 for human and mouse are based on bulk RNA-seq, microarray and scRNA-seq assays. RCA2 can also generate custom reference panels from
user-supplied raw count matrices. RCA2 computes a correlation matrix representing the similarity of each SC transcriptome to each reference transcriptome. Correlations
are calculated using marker (DE) genes from the reference panel. Cells are clustered and visualized in the space of reference projections After DE gene analysis, enriched
GO terms and KEGG pathways can be identified.

b)

300

200

100

0

40

20

0
1k

2k

5k

10k 20k 50k 100k 150k 200k

Number of cells
Version 1

Version 2

1k

2k

5k

Clustering

10k 20k 50k 100k 150k 200k

Number of cells
Graphâˆ’based

Hierarchical

D

RCA

Fig. 2. a) Speedup of the reference projection step. b) Memory consumption of
graph based clustering compared to hierarchical clustering. Benchmarking was
performed with a notebook using an Intel i9-9980 CPU(2.40GHz) and 64GB RAM.
Projecting using RCAv1 and hierarchical clustering ran out of memory using 100k
cells and 50k cell, respectively.

Rheumatoid arthritis (RA) data set benchmarking. We use a

RA data sets comprised of 5, 829 sorted cells generated by
(19). They detected plate-specific batch effects while clustering cells using the S EURAT package, which were more pronounced in some plates as compared to others. RCA2 considerably outperforms the other tested algorithms in terms of
cell type separation (Fig. 3a) but also in terms of batch robustness. While data from different plates is readily merged
together (Fig. 3b) cells cluster well according to their determined cell type (Fig. 3c). We observed that using SCT RANSFORM in the S EURAT I NTEGRATION workflow worsened both separation by batch and separation by cell type.
Cite-seq data set benchmarking. Next, we considered PBMC

CITE-seq data sequenced using (a) Drop-Seq and (b) 10X
Chromium that were analysed together as a single dataset.
Schmidt et al.

|

RCA2

CITE-Seq data contains both the antibody signature of cells
and their transcriptomic profile. Thus it provides the capability of defining a ground truth to an scRNA-seq dataset using
antibody-derived tags (ADTs). We used S EURAT to cluster
SCs in the antibody space in each of the CITE-seq datasets
and used the unique ADT signature of each cluster to annotate them (Sup. Fig. 10) (Methods).
Benchmarking on the CITE-Seq data showed that S EURAT
I NTEGRATED, MNN C ORRECT and S CANORAMA successfully reduced batch effects, similar to RCA2. However, that
was achieved at the cost of worsening cell type separation
(Fig.3d). S EURAT (Sup. Fig. S11), S CRAN and S CANPY
produced clustering results significantly affected by protocol, with S CANPY performing the best of these unsupervised
clustering methods without explicit batch correction in terms
of cell type separation. RCA2 is among the top method in
terms of batch robustness (Fig.3e) and has the best SI value
for cell types leading to a crisper separation of cell types
(Fig.3f).
Using ADT-tags of the CITE-seq data, we are able to characterize the batch not only from a technical perspective using
the SI, but also from a biological point of view: we computed
the set of DEGs that characterizes the sc capture protocol
batch within each ADT cluster (Fig.4a, Sup. Table 3). While
the majority of DEGs are ribosomal genes, we also find several genes that are both cell type and batch specific markers,
such as H3F3A, IGKC, IFI30, or IGLC2. The latter three
are related to immune reaction and gamma-interferon signaling. Another interesting gene that is associated to the batch

RA

60

Memory [GB]

Projection time [sec]

a)

bioRÏ‡iv

|

5

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

a)

NUMI
NODG
pMITO
RPS26
RPS3A
RPS28
RPS10
RPL21
EEF1A1
H3F3A
RPL39
RPL41
RPL10
RPL7
RPS27
RPL18A
RPL13A
JUND
MTâˆ’ATP6
RPS27A
PPIA
RPL22
RPS20
RPL31
RPL27A
NPM1
NCF1
PTPRCAP
SUMO2
RPS4Y1
IGKC
IGLC2
EEF1B2
TMA7
FOS
ALDOA
IFI30
ARL6IP4

D

RA

is FOS, which has been associated to several molecular processes and has been linked to cancer progression (34). As it
is known that the expression of FOS can be easily changed by
external stimuli (35), it might be more likely that, in our data
set, the observed differences in FOS expression are of technical instead of biological nature. Indeed, the RCA2 projection,
shown in Fig. 4b, is not affected by any of the DEGs linked
to the batch effects and is supporting the antibody based clustering well. The latter is also backed up by the expression of
the genes targeted by the antibodies (Sup. Fig. 12).
To characterize the genes defining the observed batch further, we investigated their GO term enrichment separately for
genes expressed in the 10X batch (Sup. Fig. 14) and the
Drop-seq batch (Sup. Fig. 15). All of the observed GO terms
can be exclusively explained by the difference in sequencing protocol and therefore potentially misguide down-stream
analysis, if less robust clustering methods are used.
We investigated this hypothesis by computing cluster specific
marker genes for clusters identified with various scRNA-seq
pipelines, using the same parameters and settings. We compared those method specific DEG to the set of batch specific
DEGs, shown in Fig.4a, using an Upset plot (Sup. Fig. 15).
Indeed, RCA2 shows the lowest overlap between cluster specific marker genes and the set of batch DEG compared to the
other methods, underlining the robustness of RCA2 towards
batch effects further.

FT

Fig. 3. a) Silhouette Index (SI) measuring separation of cells in RA data by plate and cell type. b-c) UMAP visualization of RCA2 clustering of RA data colored by b) plate
and c) cell type. d) SI measuring separation of cells in CITE-Seq data by protocol and cell type. e-f) UMAP visualization of RCA2 clustering of CITE-Seq data colored by e)
protocol and f) cell type.

Use-case on 10X PBMC data set comprising 5000
cells. We obtained a 10X dataset containing 5025 Peripheral

blood mono nuclear cells (PBMCs) from a healthy donor. We
imported the CellRanger output directly into RCA, considering cells with an UMI count â‰¥ 100.
6

|

bioRÏ‡iv

b)

CD8+ Effector Memory
CD4+ Effector Memory
CD4+ Central Memory
CD8+ Central Memory
Naive CD4+ Tâˆ’cell
Naive CD8+ Tâˆ’cell
Monocyte
Myeloid Dendritic Cell
Nonâˆ’classical Monocyte
Naive Bâˆ’Cells
Mature Bâˆ’Cells
Mature NK cell
Megakaryocyte
PDC
HPSC

CD14+ Mono
CD4+ T Memory
CD4+ T Naive
B
NK
CD8+ T Naive
CD8+ T Memory
CD8+ T Effector
CD57+ NK
CD25+ T Resting Memory
CD16+ Mono
10X
Dropseq

Expression
âˆ’2
âˆ’1
0
1
2

Correlation
âˆ’2
âˆ’1
0
1
2

Fig. 4. a) Expression of DEG computed for sequencing protocol batch within ADT
clusters. b) Reference projection of the CITE-seq data against RCA2â€™s global panel.

Upon QC using RCA2â€™s QC functionality (Sup. Fig. 15, Sup.
Table 1), the scRNA-seq data is projected against a new, manually curated reference panel of immune cell types, based on
purified populations of human hematopoietic cells (16). We
utilized the integration of Louvain graph based clustering alSchmidt et al.

|

RCA2

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

FT

Final cell type specific QC thresholds are listed in Sup. Tab.
2.
Upon QC on the level of major cell types, we used RCA2
to define cell types on a more detailed level. Using Louvain
clustering, we found the most convincing clustering in terms
of the projection heatmap using a resolution of 0.5. Doublets
have been removed at this stage with D OUBLET F INDER (21)
using the 0.97 quantile of all pANN values as a threshold,
resulting in the identification and removal of 906 doublets
(Sup. Fig. 23). Final cell type annotations, based on projection scores (Sup. Fig. 24) and backed up with DEGs (Sup.
Fig. 25, Sup. Table 5) as well as canonical markers (Sup.
Fig. 26), are indicated in the UMAP representation of the
RCA2 projection shown in Fig. 5c.
We separated the bone marrow data into two populations using magnetic bead selection as cells that are either positive or
negative for the progenitor marker CD34 (36). As shown in
Sup. Fig. 27, the RCA2 reference projection based UMAP
of the scRNA-seq data shows distinct levels of CD34 FACS
labels. These match well to the identified cell types shown in
Fig. 5c.
For example, hematopoietic stem/progenitor clusters
(HSPC), i.e. HSC/MPP, LyP-1, ERP, MEP, MyP-1 and MyP2, representing progenitor populations are almost completely
composed of cells with a CD34+ FACS label, while clusters
such as B cells or Classical Monocytes, that are composed of
differentiated cells are enriched for cells with a CD34- label
(Sup. Fig. 28a). However, we note that some clusters like
naive T cells and non-classical monocytes also had a small
contribution of 10 âˆ’ 15% from cells labelled as CD34+
cells by our MACS sorting strategy. This is not unexpected
because our workflow for purifying HSPCs lacks a prior
conventional lineage-depletion (lin-) step.CD34+ populations within the bone marrow are known to be heterogeneous
and lin- CD34+ populations were shown to mainly harbour
stem cell activity (37). Hence, our MACS sorting strategy is
expected to deliver false positives in the form of cells that are
retained in the CD34+ magnetic columns but are in reality
differentiated cells. However, RCA2 is able to identify such
lineage+CD34+ cells and clusters them correctly based on
their transcriptome. Thus, RCA2 offers a more precise
in-silico alternative to the conventional lineage-depletion
step for HSPC studies. Compared to an analysis with Seurat
using default parameters (Sup. Fig. 28b), RCA2 achieves
a better purity: In 10.05% of RCA2 clusters, the impurity
is > 20%, compared to 19.05% using Seurat. The validity
of our approach is also supported by the fact that cell type
proportions are in agreement with earlier studies (Sup. Fig.
29).
This example illustrates the ability of RCA2 to seamlessly
derive meaningful annotations and dimensionality reductions
even in highly complex datasets where cells are placed in a
continuum and the reference set might not contain exactly
matching cell types.

D

RA

gorithm into RCA2 to cluster the data using a resolution of
0.1, which leads to a sensible separation of cells in terms of
the projection heatmap (Sup. Fig. 16) as well as in the resulting number of clusters (Sup. Fig. 4). We obtained nine
clusters forming four disconnected islands in a UMAP based
on the cell to cell type correlation space obtained by the reference projection (Sup. Fig. 17a).
RCAâ€™s automated cluster annotation function determines cell
types, shown in Sup. Fig. 17b. While the B-cell cluster
(red) is very distinct from all remaining clusters, T and natural killer cells form a continuum (blue, brown, yellow, green).
Monocytes (turquiose) and non-classical monocytes (black)
appear to be well separated within a major myeloid cluster. In close proximity in UMAP space, small populations of
myeloid (pink) and plasmacytoid (magenta) dendritic cells
were identified. While the automatically determined labels
agree with the projection heatmap shown in Sup. Fig. 17a,
this can be expected by the design of RCA2 and the projection step. Therefore, we use canonical marker genes, which
are used for instance also in the S EURAT tutorial, to verify
cell types. As shown in Sup. Fig. 17c-j, the abundance of
the various marker genes corresponds well to the identified
clusters.
To further characterize the clusters, we compute DEGs in a
pair-wise manner (Sup. Fig. 7b). Sup. Table 4 lists all identified DEGs. As shown in Sup. Fig. 18, we obtain several significant terms in GO term analysis using these DE genes for
the natural killer cell cluster including cytolysis, cell killing
and cellular defense response. These are well matching to the
expected biological function of natural killer cells. Also, for
the naive CD4 T-cell cluster we obtain sensible terms such as
adaptive immune response, immune response-activating cell
surface receptor signaling pathways, and activation of immune response (Sup. Fig. 19).
This example illustrates that RCA2 allows a hassle-free analysis to characterize clusters with minimal manual efforts. The
example can be reproduced by following the online tutorial
on our github page.
Cluster specific quality control is essential to retain
high-quality cells in complex data sets. Here, we con-

sider four human bone marrow specimens separated into
CD34+ and CD34- fractions (Methods). Clustering the
RCA2 reference projection using Louvain clustering with a
resolution of 0.1, we find ten clusters representing major cell
types (Sup. Fig. 20). With RCAâ€™s cluster specific QC function, we observed that the various cell types included in the
dataset do require different QC thresholds (Sup. Fig. 21)
For instance, the average NODG for the lymphoid population, e.g. B or T cells, is around 1, 000, while the NODG
of progenitor cells can be up to three fold higher. Similarly,
the percentage of mitochondrial reads shows different distributions. While it has low standard deviation for Pro-B cells,
it values spread out widely e.g. for Classical Monocytes. As
indicated by the color code in Fig. 5a, cluster agnostic thresholds (Sup. Fig. 22) would result in a substantial loss of cells,
which is quantified for the final clusters in Fig. 5b and clearly
illustrates the importance of a (major) cell type specific QC.
Schmidt et al.

|

RCA2

RCA2 clusters PBMCs from COVID-19 patients more
robustly than de-novo approaches. Using scRNA-seq

PBMC data obtained from seven COVID-19 patients and six
bioRÏ‡iv

|

7

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

a)

b)
Classical Monocytes

ERP

Erythroblasts

1.00

HSC/MPP

Discarded/Total

B Cells
0.10
0.08
0.06
0.04

0.75
0.50
0.25

âˆ’2

N

c)

0.04
10
Nonâˆ’classical monocytes

pDC

ProBâˆ’1

ProBâˆ’2

B Cells
Classical
Monocytes
ERP
Erythroâˆ’
blasts
HSC/MPP
MEP
MLP
MyPâˆ’1
MyPâˆ’2
NK
Nonâˆ’Classical
Monocytes
pDC
ProBâˆ’1
ProBâˆ’2
T Memory
T Naiveâˆ’1
T Naiveâˆ’2
T Naiveâˆ’3
T TEMRA

T Memory

0.10
5

0.08
0.06
0.04

T Naiveâˆ’1

T Naiveâˆ’2

T Naiveâˆ’3

2000

T TEMRA

4000

0.10

6000

UMAP2

Percent mitochondrial genes

0.08
0.06

on
N
M âˆ’cla K
on s
oc sic
yt al
es
pD
C
Pr
oB
âˆ’1
Pr
oB
âˆ’2
T
M
em
or
T
y
N
ai
ve
âˆ’1
T
N
ai
ve
âˆ’2
T
N
ai
ve
âˆ’3
T
TE
M
R
A

âˆ’1

yP

LP

yP

M

B

M

NK

EP

MyPâˆ’2

M

MyPâˆ’1

M

MLP

C
el
l
M Cla s
on s
oc sic
yt al
es
Er
ER
yt
P
hr
ob
la
s
H
SC ts
/M
PP

0.00
MEP
0.10

0

âˆ’5

0.08

Retained
Lenient

0.06

Strict

0.04
2000

4000

6000

2000

4000

6000

2000

4000

6000

2000

4000

6000

âˆ’10

âˆ’15

NODG

âˆ’10

âˆ’5

0

5

10

UMAP1

Fig. 5. a) Cluster-specific QC based on NODG and pMito. Colors indicates whether cells are discarded (red, blue) or retained (black) if general, cluster-unspecific QC would
be used. b) Proportions of cells discarded per cell type using cluster unspecific QC. c) UMAP reduction of a multi panel RCA2 projection coloured by cell type using a
resolution of 0.5.

FT

positioned within the Myelocyte & Neu group, which consistently showed high expression of premature neutrophil granule genes in our RCA2 analysis (Sup. Fig. 32a). The remaining 75 cells were either low quality/doublets (32 cells)
or other cell types (Sup. Fig. 32b). Particularly, 29 DN were
annotated as CD14 monocytes by RCA. In order to ascertain that the RCA2 approach did correctly cluster and annotate these DN, we compared the RCA2 reference projection
profiles and feature genes between the 131 and 29 DN annotated as myelocytes and CD14 monocytes in the RCA2
analysis respectively (Sup. Fig.32c,d). Indeed, the former
131 DN showed high correlation with the transcriptome reference of myelocytes, while the latter 29 DN were highly
correlated with CD14 monocytes with high expression of the
marker genes such as CD14 and CD300E (39)) (Sup. Fig.
32d). Therefore, RCA2 has precisely segregated these DN
into their real cell types.

RA

healthy donors, Wilk et al. reported a developing neutrophil
(DN) population that seemingly showed a phenotypic relation with plasmablasts in dimensionality reduction (22). Wilk
et al. hypothesized a lymphocyte-to-granulocyte differentiation process to be associated with severe COVID-19 infection. However, as raised by (38), this UMAP based interpretation contradicts the principle cell lineage fate. By projecting all of 44, 721 cells analyzed by Wilk et al. to immune
reference panels in RCA2, we identified that a large portion
of cells were actually low quality cells or potential doublets
(Fig.6a).

D

We identified 32 clusters using graph-based clustering (resolution 1.3) on the reference projection of all 44, 721 cells
(Sup.Fig. 30, 31a). Seven clusters (darkorange, darkred,
green, greenyellow, lightcyan and lightgreen) exhibit ambiguous projection profiles showing high correlations with
multiple cell types from distinct lineages, suggesting that
these cells are either of low quality or doublets (Sup. Fig.
31b). Additional marker gene profiling coupled with a
NODG comparison supported this hypothesis (Sup. Fig.
31c,d). For instance, clusters darkred and darkorange had
high correlations with monocytes and T cells, respectively
(Sup. Fig. 31b). However, both of them also showed high
transcriptomic correlations with red blood cells (RBC), implying that these cells could be contaminated by RBC (Sup.
Fig. 31b). We observed high expression levels of RBC genes,
such as GYPA and HBB, in these two clusters (Sup. Fig. 31c)
and significantly lower NODG of these two clusters comparing to monocytes and T cells respectively (Sup. Fig. 31d).

Next, we pinpointed the location of the 206 developing neutrophils (DN) annotated by Wilk et al. within our RCA2
UMAP, and found these cells to be a mixture of different
cell types (Fig. 6b). Similar to the initial SingleR annotation for the DN cluster made by Wilk et al., 131 cells were
8

|

bioRÏ‡iv

Interestingly, we did not observe the phenotypic relation
by dimensionality reduction between RCA-annotated myelocytes and plasmablasts as described by Wilk et al. (Fig.6a).
In order to assess the transcriptomic similarity between
myeloid-derived myelocytes and lymphoid-derived plasmablasts, we charted the UMAP embedding and compared
the DEGs across these cell types (Fig.6c). As comparison
control, we also included myeloid-derived monocytes and
DCs in the analysis (Fig.6c). As expected, myelocytes and
plasmablasts did not form a differentiation bridge between
them, and a clear difference at the gene-expression level were
characterized between these two cell types (Fig.6c-e). Presumably, the initial findings of the differentiation bridge between DN and plasmablasts by Wilk et al. could be due to
the presence of low-quality cells and doublets. Indeed, after
removing these sub-optimal cells and applying the same analysis pipeline used by the authors, we observed distinct sepSchmidt et al.

|

RCA2

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

a)

b)
10

10

5

UMAP2

UMAP2

5

0

0

âˆ’5

âˆ’5

âˆ’15

âˆ’10

âˆ’5

0

5

UMAP1
COVID

âˆ’10

âˆ’5

0

5

10

UMAP1
Healthy

AML

Control

Fig. 7. a) UMAP embedding of a reference projection for the Covid-19 PBMC data
set from (22). b) UMAP embedding of a reference projection for the AML dataset
809653 from (23). AML and control cells are well separated in reference space.

FT

tients, whereas five clusters are composed of more than 75%
of cells from Covid-19 patients, despite no disease specific
reference cell types are included in our panels.
For the AML data set we obtain a clearer picture. According
to the authors classification of cells, AML and healthy cells
separate almost perfectly in the RCA2 projection although no
AML samples are included in the reference panels (Fig.7b.).
This separation is also reflected in the cluster composition
plot (Sup. Fig. 33b).

DISCUSSION AND CONCLUSIONS

RA

Although de novo clustering is currently the predominant
strategy to cluster scRNA-seq data, it does have some disadvantages, the most important of which is vulnerability to
batch effects. Consequently, de novo clustering necessitates
use of explicit batch-effect correction (4). However, one fundamental problem with batch correction is that it cannot distinguish between technical variation and genuine biological
differences. Hence, when batch and biology are confounded,
there is a risk of erroneously suppressing biological variation. Since reference-based methods can mitigate this problem, mapping of SCs to a reference atlas has recently been
identified as one of the grand challenges in the SC field (40).
RCA2 directly addresses this challenge.
Indeed, our benchmarking of batch effect robustness supports the above expectation. In two independent benchmarks,
RCA2 was the best performer in clustering cells by cell type
rather than batch, even without explicit batch correction (Fig.
3,4). Consistently with this finding, DEGs between clusters
reflected cell type identity in the case of RCA2, but batch
effects in the case of de novo clustering. Importantly, in addition to being robust to batch effects, RCA2 is able to detect
cell types and states not present in the reference panel (Fig.
5,7). This capability of RCA2 implies that novel cell states
could potentially be discriminated even when projected onto
reference transcriptomes.
One inter-operability advantage of RCA2 is that count matrices from Seurat can be imported. In return, RCA2 results can be incorporated into a Seurat object. In terms of
scalability, RCA2 is a key improvement over the initial release: RCA2 memory usage grows linearly with the number
of cells, unlike the quadratic scaling of RCA (Fig. 2). Also,
execution time is over ten-fold faster on large datasets. In ad-

D

Fig. 6. a) UMAP shows the RCA2 clustering of cells from the COVID-19 study by
Wilk et al. b) The location of developing neutrophils annotated by Wilk et al. are
marked as red dots in the RCA2 UMAP. c) UMAP represents the sub-clustering of
CD14 monocytes, CD16 monocytes, myelocytes, neutrophils, and plasmablasts using an unsupervised approach. d) Bubble plot shows the marker gene expression
levels across the identified cell types from c. Bubble size indicates expression percentage for each cell type, while color intensity represents scaled expression levels.
e) Heatmap shows the expression profiles of cell-specific genes across the identified cell types from c. f) UMAP plot shows the cell clustering using the analysis
pipeline by Wilk et al. after removing low-quality cells and doublets.

aration between DN and plasmablasts (Fig.6f). Altogether,
RCA2 has provided a more precise clustering and UMAP visualization of PBMCs from this COVID-19 study.
Reference based clustering is able to capture disease
states of cells. To address a prevalent misconception that

supervised clustering algorithms are unable to identify novel
cell types and cell states, we used RCA2 to project and to
cluster two publicly available data sets: one Acute Myeloid
Leukemia (AML) data set (23) as well as the already introduced Covid-19 dataset (22). Note that no additional QC was
performed and data is used as provided by the authors. We
refer to the Methods section for further processing details.
As shown in Fig. 7a, we observe that PBMCs from the Covid19 data occur both in condition specific and in shared neighbourhoods. This is an expected behaviour and corresponds
well to the original findings of (22). Upon clustering the
data in RCA, we obtained 28 clusters. As shown in Sup. Fig.
33a, several clusters are depleted for cells from Covid-19 paSchmidt et al.

|

RCA2

bioRÏ‡iv

|

9

bioRxiv preprint doi: https://doi.org/10.1101/2021.02.16.431527; this version posted February 17, 2021. The copyright holder for this preprint
(which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made
available under aCC-BY-NC 4.0 International license.

FT

13. Daniel MÃ¼llner. fastcluster: Fast hierarchical, agglomerative clustering routines for R and
Python. Journal of Statistical Software, 53(9):1â€“18, 2013.
14. Michael Hahsler et al. dbscan: Fast density-based clustering with R. Journal of Statistical
Software, 91(1):1â€“30, 2019. doi: 10.18637/jss.v091.i01.
15. G. Yu et al. clusterProfiler: an R package for comparing biological themes among gene
clusters. OMICS, 16(5):284â€“287, May 2012.
16. N. Novershtern et al. Densely interconnected transcriptional circuits control cell states in
human hematopoiesis. Cell, 144(2):296â€“309, Jan 2011.
17. Marlon Stoeckius et al. Simultaneous epitope and transcriptome measurement in single
cells. Nature methods, 14(9):865, 2017.
18. G. Monaco et al. RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute
Deconvolution of Human Immune Cell Types. Cell Rep, 26(6):1627â€“1640, 02 2019.
19. Fan Zhang et al. Defining inflammatory cell states in rheumatoid arthritis joint synovial
tissues by integrating single-cell transcriptomics and mass cytometry. Nature immunology,
20(7):928â€“942, 2019.
20. Tamar Hashimshony et al. Cel-seq2: sensitive highly-multiplexed single-cell rna-seq.
Genome biology, 17(1):77, 2016.
21. C. S. McGinnis et al. DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing
Data Using Artificial Nearest Neighbors. Cell Syst, 8(4):329â€“337, 04 2019.
22. A. J. Wilk et al. A single-cell atlas of the peripheral immune response in patients with severe
COVID-19. Nat Med, 26(7):1070â€“1076, 07 2020.
23. A. A. Petti et al. A general approach for detecting expressed mutations in AML cells using
single cell RNA-sequencing. Nat Commun, 10(1):3660, 08 2019.
24. Aaron TL Lun et al. A step-by-step workflow for low-level analysis of single-cell rna-seq data
with bioconductor. F1000Research, 5, 2016.
25. L. Haghverdi et al. Batch effects in single-cell RNA-sequencing data are corrected by matching mutual nearest neighbors. Nat Biotechnol, 36(5):421â€“427, 06 2018.
26. B. Hie et al. Efficient integration of heterogeneous single-cell transcriptomes using
scanorama. Nature biotechnology, 37(6):685â€“691, 2019.
27. C. Hafemeister and R. Satija. Normalization and variance stabilization of single-cell RNAseq data using regularized negative binomial regression. Genome Biol, 20(1):296, 12 2019.
28. Peter J Rousseeuw. Silhouettes: a graphical aid to the interpretation and validation of
cluster analysis. Journal of computational and applied mathematics, 20:53â€“65, 1987.
29. Yuhan Hao et al. Integrated analysis of multimodal single-cell data. bioRxiv, 2020. doi:
10.1101/2020.10.12.335331.
30. C. A. Davis et al. The Encyclopedia of DNA elements (ENCODE): data portal update.
Nucleic Acids Res., 46(D1):D794â€“D801, 01 2018.
31. Fionn Murtagh and Pierre Legendre. Wardâ€™s hierarchical agglomerative clustering method:
which algorithms implement wardâ€™s criterion? Journal of classification, 31(3):274â€“295,
2014.
32. M. Ashburner et al. Gene ontology: tool for the unification of biology. The Gene Ontology
Consortium. Nat. Genet., 25(1):25â€“29, May 2000.
33. M. Kanehisa and S. Goto. KEGG: kyoto encyclopedia of genes and genomes. Nucleic
Acids Res., 28(1):27â€“30, Jan 2000.
34. E. Tulchinsky. Fos family members: regulation, structure and role in oncogenic transformation. Histol. Histopathol., 15(3):921â€“928, 07 2000.
35. P. Patronas et al. Differential stimulation of c-fos expression in hypothalamic nuclei of the
rat brain during short-term heat acclimation and mild dehydration. Brain Res., 798(1-2):
127â€“139, Jul 1998.
36. C. I. Civin et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell
surface antigen defined by a monoclonal antibody raised against KG-1a cells. J. Immunol.,
133(1):157â€“165, Jul 1984.
37. D. Pellin et al. A comprehensive single cell transcriptional landscape of human hematopoietic progenitors. Nat Commun, 10(1):2395, 06 2019.
38. JosÃ© Alquicira-Hernandez et al. No evidence that plasmablasts transdifferentiate into developing neutrophils in severe covid-19 disease. bioRxiv, 2020. doi: 10.1101/2020.09.27.
312538.
39. T. Brckalo et al. Functional analysis of the CD300e receptor in human monocytes and
myeloid dendritic cells. Eur J Immunol, 40(3):722â€“732, Mar 2010.
40. D. Laehnemann et al. Eleven grand challenges in single-cell data science. Genome Biol.,
21(1):31, 02 2020.

RA

dition, RCA2 incorporates multiple new reference panels for
human and mouse and also supports generation of new panels from user-supplied transcriptome data. RCA2 also provides multiple features for data visualization and interpretation, such as generation of editable (ggplot2) figures, KEGG
and GO enrichment analysis (Fig. 1). Lastly, RCA2 simplifies cluster-specific QC, which is essential for discarding
low-quality cells and doublets in SC data from heterogeneous
samples (Fig. 5).
QC can have a severe effect on clustering, particularly de
novo clustering. Indeed, our re-analysis of a recently published COVID-19 dataset showed that known cell type markers showed clear cluster-specific expression only after QC using RCA2 (Fig. 6d). In contrast, reference-based clustering
using RCA2 was robust to the presence of low-quality cells
and doublets (Sup. Fig. 31). Importantly, the "developing
neutrophils" identified as plasmablast-derived in the previous
study formed a novel cluster after QC that was clearly distinct
from plasmablasts.
Overall, we demonstrated that reference-based clustering of scRNA-seq data has unique advantages and provides a complementary strategy to widely-used unsupervised approaches. RCA2, which is freely available on
github (https://github.com/prabhakarlab/RCAv2), provides
the single-cell community with a robust, scalable and easyto-use R-package that can be easily integrated into existing
workflows to leverage these advantages. We will continue to
maintain and enhance RCA2, for example by expanding the
set of reference panels and by adding more clustering strategies downstream of reference projection. Given the potential
of reference-based methods for SC data analysis, we believe
that such methods may in future also prove useful in analyzing multi-modal SC data.

D

ACKNOWLEDGEMENTS
The authors thank all members of the Prabhakar lab for testing and providing feedback on the functionality and user-friendliness of RCA2.
Funding. CDAP201703-172-76-00056 and IAF-PP-H18/01/a0/020 from the
Agency for Science, Technology and Research, Singapore and CIRG16nov032
as well as NMRC/CIRG/1468/2017 from the National Medical Research Council,
Singapore and MOH-CSASI18may-0002 from the Ministry of Health, Singapore.

Bibliography
1. F. Tang et al. mRNA-Seq whole-transcriptome analysis of a single cell. Nat. Methods, 6(5):
377â€“382, May 2009.
2. Editorial. Method of the year 2013. Nat. Methods, 11(1):1, Jan 2014.
3. D. A. Lawson et al. Tumour heterogeneity and metastasis at single-cell resolution. Nat. Cell
Biol., 20(12):1349â€“1360, 12 2018.
4. V. Y. Kiselev et al. Challenges in unsupervised clustering of single-cell RNA-seq data. Nat.
Rev. Genet., 20(5):273â€“282, 05 2019.
5. H. Li et al. Reference component analysis of single-cell transcriptomes elucidates cellular
heterogeneity in human colorectal tumors. Nat. Genet., 49(5):708â€“718, May 2017.
6. T. Abdelaal et al. A comparison of automatic cell identification methods for single-cell RNA
sequencing data. Genome Biol., 20(1):194, 09 2019.
7. A. Butler et al. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol., 36(5):411â€“420, 06 2018.
8. F. A. Wolf et al. SCANPY: large-scale single-cell gene expression data analysis. Genome
Biol., 19(1):15, 02 2018.
9. S. Freytag et al. Comparison of clustering tools in R for medium-sized 10x Genomics singlecell RNA-sequencing data. F1000Res, 7:1297, 2018.
10. D. Aran et al. Reference-based analysis of lung single-cell sequencing reveals a transitional
profibrotic macrophage. Nat. Immunol., 20(2):163â€“172, 02 2019.
11. R. Hou et al. scMatch: a single-cell gene expression profile annotation tool using reference
datasets. Bioinformatics, 35(22):4688â€“4695, Nov 2019.
12. Hamada S. Badr et al. A tool for hierarchical climate regionalization. Earth Science Informatics, 8(4):949â€“958, 2015. doi: 10.1007/s12145-015-0221-7.

10

|

bioRÏ‡iv

Schmidt et al.

|

RCA2

